Literature DB >> 31056689

Efficacy of sarilumab in adult-onset Still's disease as a corticosteroid-sparing agent.

Sylvain Raoul Simeni Njonnou1,2, Muhammad Shahnawaz Soyfoo3, Frédéric-Alain Vandergheynst2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31056689     DOI： 10.1093/rheumatology/kez154

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Adult-Onset Still's Disease with Dermatopathic Lymphadenitis Clinicopathologic Features: A Rare Case Report and Review of the Literature.

Authors:  Reda A Elhawary; Mir Nadeem; Mohammed S Abdelwahed; Mansour Somaily; Shahenda Y Alemam
Journal:  Case Reports Immunol       Date:  2022-06-03

Review 2.  Progress in Biological Therapies for Adult-Onset Still's Disease.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Paolo Sfriso
Journal:  Biologics       Date:  2022-04-21

Review 3.  New insights on multigenic autoinflammatory diseases.

Authors:  Petros Efthimiou; Olga Petryna; Priscila Nakasato; Apostolos Kontzias
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-03       Impact factor: 3.625

Review 4.  [What is confirmed in the treatment of autoinflammatory fever diseases?]

Authors:  Anne Pankow; Eugen Feist; Ulrich Baumann; Martin Kirschstein; Gerd-Rüdiger Burmester; Annette Doris Wagner
Journal:  Internist (Berl)       Date:  2021-12-08       Impact factor: 0.743
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.